ʻO ka maikaʻiʻana o ka kūʻai akuʻana i nā mea'aloʻohi oncology me Herceptin a me Avastin
ʻO nā lāʻau lapaʻau e hoʻouluhua nei i kaʻoihanaʻoihana kālaihana. Loaʻa kaʻokoʻa o nā pūʻali nui i ka lāʻau lapaʻau iʻole e loaʻa i nā lāʻau lapaʻau i ko lākou paepae lāʻau i loaʻa nā lāʻau i loaʻa i nā makahiki e hiki mai ana.
ʻO ke kūlana kiʻekiʻe o nā lāʻau o Oncology
Hoʻopilikia ka maʻi i nā miliona o ka poʻe i kēlā me kēia makahiki, a me ka hoʻomauʻana o ka poʻe o ka honua i ka ulu, hiki i ka nui o nā mea maʻi maʻi hou ke ulu aʻe. ʻO nā hanana hou i loko o kaʻoihana hana lāʻau kālaika i hiki ke loaʻa i ka maʻi kanesa i nā manawa he nui.
He nui nā lāʻau hou i hoʻokeleʻia i nāʻano o ka maʻi kanesa, e uku ana i ka uku kumukūʻai a me ka hakakāʻana i ka hoʻokūkū liʻiliʻi. A no ka loaʻaʻole o nāʻano lāʻau likeʻole lāʻau likeʻole me ka hoʻohanaʻana i nā lāʻau lapaʻau, uaʻoi aku ka lōʻihi o ko lākou ola ma keʻano o ka pale patent. ʻO ia keʻano o nā mea hana lāʻau lāʻau e hiki ke hoʻomau i ke koiʻana i nā kumukūʻai a lākou iʻike ai no ka loaʻaʻole o kā lākou mau lāʻau lapaʻau.
ʻO kaʻoihana olakino a 20 ke kūʻaiʻana o ka lāʻauʻona e hoʻopuka i nā kūʻai kūʻai makahiki ma kahi $ 50 biliona ma ka honua holoʻokoʻa. ʻO Roche's Rituxan, Avastin, a me Herceptin e alakaʻi i ke kī, a me $ 21 bilikani kūʻai no kēia mau huaaleʻekolu wale nō. ʻO ka lalani topcology o Roche kahi i hōʻikeʻia e pili ana i ka 40 pakeneka o ka 20 ma luna o nā kūʻai kūʻai.
ʻOihanaʻOihana Oncology Drugs
Loaʻa he koi nuiʻana i nā mea a pau e pili ana i nā lāʻau no ke kinaika, no laila,ʻike nā kamaliʻi lapaʻau i ka ulu nui ma waho o kā lākou mau maʻamau maʻamau iʻAmelika Hui Pūʻia a meʻEulopa.
ʻO ka hoʻolālāʻana i ka hoʻolālā hoʻolālā i nā'Āina Asia e like me Kina a me Iapana ke hana i nā lāʻau i hiki ke maʻalahi. ʻO ka hoʻonuiʻana i ka papa waena ma India, no ka uluʻana o nāʻoihana hoʻolaha kālai lāʻau i nā hale'ēhana India, hiki ke hāʻawi i nāʻoihana mālama kālāʻoi aku i nā mea hiki ke loaʻa.
01 Avastin
Ka Hui a iʻole nā maʻi i hoʻoponoponoʻia: Ka umauma, ka pale, ka pala, ka'ōkena, nā kāpena maʻi wahine
ʻO ke kūʻaiʻana o nā mea kūʻai : $ 6.7 piliona
Inoa inoa: Bevacizumab
02 Revlimid
Mea hana: Celgene
Hoʻohana a iʻole nā maʻi i hoʻoponoponoʻia: Kaumelike maha
ʻO ke kūʻaiʻana o nā mea kūʻai : $ 4.2 biliona
Kapa inoa: Lenalidomide
03 Rituxan
Mea hana: Roche
Ka Hui a iʻole nā maʻi i hoʻoponoponoʻia: Non-Hodgkins Lymphoma, maʻi leukemia lymphocytic
ʻO ke kūʻaiʻana o nā mea kūʻai : $ 7.5 piliona
Kapa inoa inoa: Ritimimab
04 Herceptin
Mea hana: Roche
Ka Hui a iʻole nā maʻi i hōʻoiaʻia : HER2 + maʻi kanulau
ʻO ke kūʻaiʻana o nā mea kūʻai : $ 6.5 piliona
Kapa inoa inoa: Trastuzumab
05 Imbruvica
Mea Hana: Johnson & Johnson / Pharmacyclics
Ka Hoʻohui a iʻole nā maʻi i hoʻoponoponoʻia: M lymphoma Mantel cell, leukemia liʻiliʻi lymphocetic
Global Sales: $ 5.3 piliona
Kahi inoa: Ibrutinib capsules
06 Holoholo
Mea Hana: Novartis
Ka Hui a iʻole nā maʻi i hoʻoponoponoʻia: Līkia mieloid leukemia, nā maʻi koko steromalinal
ʻO ke kūʻaiʻana o nā mea kūʻai : $ 4.7 piliona
Inoa inoa: Imatinib
07 Alimta
Mea Hana: Eli Lilly
Ka Hui a iʻole nā maʻi i hōʻoiaʻia: Ka maʻi kanesa liʻiliʻi liʻiliʻi
Nā kūʻai kūʻai maʻamau : $ 2.5 biliona
Kapa inoa inoa: Pemetrexed
08 Hōʻike
Mea hana: Johnson & Johnson / Takeda
Ka Hoʻohui a iʻole nā maʻi i hoʻoponoponoʻia:ʻO ka myeloma maha,ʻo ke lymphoma lyup
ʻO ke kūʻaiʻana o nā mea kūʻai : $ 2.6 piliona
Inoa inoa: Bortezomib
09ʻO Erbitux
Mea Hana: BMS / Merck Serono
Ka Hui a iʻole nā maʻi i hoʻoponoponoʻia: Pāpale'ā'ī, poʻo a me ka'ā'ī
ʻO ke kūʻaiʻana o nā mea kūʻai : $ 1.9 piliona
ʻO ka inoa o ka inoa Genusima
10 Ke kauhale
Mea hana: Merck & Co.
Ka Hui a iʻole nā maʻi i hōʻoiaʻia : Cervical cancer
ʻO ke kūʻaiʻana o nā mea kūʻai : $ 1.8 piliona
Kāinoa Generic: Papillomavirus Quadrivalent (Keʻano 6,11, 16, a me 18) Līkini, Recombinant]
11 Zytiga
Mea hana: Johnson & Johnson
Ka Hoʻohui a iʻole nā maʻi i hōʻoiaʻia : Ka maʻi'ānetene
ʻO ke kūʻaiʻana o nā mea kūʻai : $ 1.7 piliona
Kapa inoa inoa: Abiraterone acetate
12 Xeloda
Mea hana: Roche
Ka Hoʻohanohano a iʻole ka maʻi: I ka umauma, i nā maʻi lapaʻau
Global Sales: $ 1.6 biliona
Kapa inoa inoa: Capecitabine
13 Kekahi
Mea hana: Roche
Ka Hui a iʻole nā maʻi i hōʻoiaʻia:ʻO ka'ōpū liʻiliʻi liʻiliʻi, nā maʻi maʻi pancreatic
Global Sales: $ 1.4 piliona
Inoa inoa: Erlotinib
14 E hana
Mea Hana: Novartis
Ka Hui a iʻole nā maʻi i hoʻoponoponoʻia: Ka maʻi maʻi o ka maʻi
Global Sales: $ 1.3 piliona
Inoa inoa: Everolimus
15 Manaʻo
Mea Hana: Novartis
Ka Hui a iʻole nā maʻi i hoʻoponoponoʻia: Ka maʻi mieloid leukemia
Global Sales: $ 1.3 piliona
Inoa inoa: Nilotinib
16 Kani
Mea hana: Pfizer
Ka Hoʻohui a iʻole nā maʻi i hoʻoponoponoʻia: Sarcoma salina pūnana, nā pūpū stromal gastrointestinal
Global Sales: $ 1.2 biliona
Inoa inoa: Sunitinib Malate
17 Nexavar
Mea Hana: Bayer
Ka Hui a iʻole nā maʻi i hoʻoponoponoʻia: Sarcoma pūnoa pū, ka maʻi o ka ate
Global Sales: $ 1 biliona
Kapa inoa inoa: Sorafenib
18 Xgeva
Mea hana: Amgen
Ka Hui a iʻole nā maʻi i hoʻoponoponoʻia: Bone mestases
Global Sales: $ 1 biliona
Inoa inoa: Denosumab
19 Zoladex
Mea hana: AstraZeneca
Ka Hoʻohui a iʻole nā maʻi i hoʻoponoponoʻia: ka umauma, ka maʻi hānai
Global Sales: $ 1 biliona
Kapa inoa inoa: Goetrelin acetate
20ʻO Iowa
Mea hana: BMS
Ka Hui a iʻole nā maʻi i mālamaʻia: Melanoma
Global Sales: $ 960 miliona
Kapa inoa inoa: Ipilimumab